Market For COVID-19 Therapeutics Will Exceed Government Demand, US Believes
HHS Secretary Azar says $1bn of the $2.5bn emergency supplemental funding request is for vaccine development.
You may also be interested in...
The US government has a routine approach for negotiating single-seller/single-buyer contracts, but drug pricing politics and public fears of coronavirus will likely complicate any purchasing talks with a sponsor, should an effective vaccine or therapeutic emerge.
Sen. Alexander says Congress should consider options to alleviate US dependence on other countries for drug and medical supply production once the outbreak subsides.
When the top US health official testified before Congress on the budget this past week, drug pricing was barely discussed. What a difference two weeks – and global spread of a novel infectious disease – makes.